Mergers & Acquisitions ·
Clarivate Plc entered into a Stock and Asset Purchase Agreement to sell its Life Sciences and Healthcare business to…
CLVTClarivate PLC
Clarivate Plc entered into a Stock and Asset Purchase Agreement to sell its Life Sciences and Healthcare business to an affiliate of Altaris, LLC for an aggregate purchase price of $600,000,000. The consideration includes $500,000,000 in cash at closing, $25,000,000 in deferred consideration payable by January 31, 2028, and $75,000,000 in unsecured senior notes. The transaction is expected to close by the end of 2026. Clarivate provides information services and analytics for professional industries.